Nexus Surgical & Medicare Limited has issued a clarification to BSE Limited regarding recent significant price movements in its securities, responding to a surveillance department inquiry dated January 2, 2026.

Company's Response to BSE Inquiry

The healthcare company addressed BSE's email reference No. L/SURV/ONL/PV/AJ/2025-2026/3264 through an official communication dated January 3, 2026. The response was signed by Managing Director Ram Swaroop Joshi (DIN: 07184085) and submitted to BSE's surveillance department at Phiroze Jeejeebhoy Towers, Mumbai.

Market-Driven Price Movement

Nexus Surgical and Medicare Limited attributed the significant price movement in its securities to market conditions, describing it as purely market-driven. The company emphasized that the volatility was not linked to any specific corporate developments or undisclosed information.

The management clarified that there is no undisclosed or price-sensitive information requiring disclosure to the exchange at this time. Additionally, the company confirmed no impending announcements or corporate actions that would necessitate immediate market notification.

Regulatory Compliance Assurance

The company reaffirmed its commitment to regulatory compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Key compliance aspects highlighted include:

• Prompt information sharing with stock exchanges on operational matters
• Timely disclosure of events affecting company performance
• Continued adherence to material event reporting requirements
• Ongoing commitment to transparency in corporate communications

Nexus Surgical and Medicare Limited assured BSE that it will continue to promptly inform exchanges of all material events, information, and actions as required under the regulatory framework. The company's registered address is located at Gala No. 4, Building No. 1, Saarthak Square Industrial Park, Sativali, Vasai (East), Palghar.

Nexus Surgical & Medicare Limited, a trading-focused company, has reported a significant increase in its net profit for the quarter ended June 30, despite a slight dip in revenue. The company's financial performance shows resilience in managing expenses while improving profitability.

Financial Highlights

Nexus Surgical & Medicare Limited has posted a net profit of ₹15.25 lakhs for the quarter, marking a substantial 69.6% increase from ₹8.99 lakhs reported in the same quarter of the previous year. This impressive growth in profitability comes despite a marginal decrease in total income, which stood at ₹172.52 lakhs, down 2% from ₹176.03 lakhs in the corresponding quarter last year.

Revenue and Expense Management

The company's revenue from sales and services declined slightly to ₹172.52 lakhs from ₹176.03 lakhs year-over-year. However, Nexus Surgical & Medicare demonstrated effective cost management, with total expenses decreasing to ₹152.15 lakhs from ₹164.04 lakhs in the previous year's quarter, representing a 7.2% reduction.

Improved Profitability Metrics

The company's earnings per share (EPS) saw a significant improvement, rising to ₹0.28 from ₹0.16 in the corresponding quarter last year, reflecting a 75% increase. This growth in EPS outpaced the increase in net profit, indicating enhanced value creation for shareholders.

Operational Insights

According to the company's statement, Nexus Surgical & Medicare Limited is primarily engaged in the trading business and operates without separate reportable business segments. The company reported no shareholder complaints during the quarter, suggesting stable investor relations.

Management Commentary

Ram Swaroop Joshi, Managing Director of Nexus Surgical & Medicare Limited, stated, "The Board of Directors has approved the Unaudited Quarterly Financial Results of the Company for the quarter ended 30th June. We are pleased with the significant improvement in our profitability despite the slight decrease in revenue. Our focus on efficient expense management has yielded positive results, as reflected in our financial performance this quarter."

Conclusion

Nexus Surgical & Medicare Limited's Q1 results demonstrate the company's ability to enhance profitability through effective cost control measures, even in the face of slightly reduced revenue. The substantial increase in net profit and earnings per share highlights the company's improved operational efficiency and financial management.

Investors and stakeholders will likely be watching closely to see if Nexus Surgical & Medicare can maintain this momentum in the coming quarters, particularly in terms of revenue growth while sustaining its improved profit margins.